UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004822
Receipt No. R000005742
Scientific Title A phase II study of first-line gefitinib for advanced and recurrent EGFR mutation positivenon-small cell lung cancerwith high-risk factors
Date of disclosure of the study information 2011/01/05
Last modified on 2017/07/11 09:38:37

No. Disposal Last modified on Item of update
1 Insert 2011/01/05 15:22:11
2 Update 2015/05/28 10:55:33 Recruitment status
3 Update 2017/07/11 09:32:42 Recruitment status
4 Update 2017/07/11 09:38:37 Address
Address
TEL
Email
Address
Address
TEL
Email
TEL
Name of primary sponsor
Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.


Contact us.